Filing Flows › CME Group (CME) › Q2 2026
CME Group (CME) Q2 2026 earnings results (second quarter 2026)
10-Q filed Jul 24, 2026
CME Group (CME) reported revenue of $1.7B for the second quarter 2026 (Q2 2026), +0.8% from a year earlier and -9% from the quarter before. Operating margin was 64.9%, net earnings $1.0B (61.1% of revenue).
CME Group, Q2 2026: revenue $1.7B (+0.8% year over year), operating margin 64.9%, net earnings $1.0B, operating cash flow $947M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7B | -9% | +0.8% |
| Operating profit | $1.1B | -15% | -2% |
| Net earnings | $1.0B | -10% | +2% |
| Operating cash flow | $947M | -25% | -11% |
| Free cash flow | $924M | -25% | -11% |
What changed
Revenue was $1.7B in Q2 2026, up 1% year over year and down 9% from the previous quarter. Clearing and transaction fees was the largest line at 79% of revenue. Market data and information services added $0.04B year over year (up 20%), 282% of the total change. Clearing and transaction fees declined 3%.
Operating profit was $1.1B, a 64.9% margin (down 1.9 points year over year). Operating profit fell $0.02B even though revenue rose $0.01B versus Q2 2025, so costs grew faster than sales. Total costs grew 6% against revenue growth of 1%. Net earnings were $1.0B, up 2% year over year. The effective tax rate was 21.5%.
Operating cash flow was $0.95B (down 11% year over year), 91% of net earnings. Non-cash charges added back $0.08B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.20B. Capital expenditures of $0.02B left free cash flow of $0.92B.
Questions
What was CME Group's revenue in the second quarter 2026?
CME Group (CME) reported revenue of $1.7B for the second quarter 2026 (Q2 2026), +0.8% from a year earlier and -9% from the quarter before.
Was CME Group profitable in the second quarter 2026?
Operating profit was $1.1B (64.9% of revenue) and net earnings $1.0B.
Source: CME Group 10-Q on SEC EDGAR.